Clinical trials
Sexually Transmitted Diseases trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2 |
| BCN Checkpoint | 1 |
| GlaxoSmithKline | 1 |
| Hendrik Streeck | 1 |
| Hospital Universitario Infanta Leonor | 1 |
| Hospital Universitario de Valme | 1 |
| Hospitales Universitarios Virgen del Rocío | 1 |
| Parc de Salut Mar | 1 |
| Rob Gruters | 1 |
| University of Seville | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sexually Transmitted Diseases | 12 |
| HIV Infections | 4 |
| Acquired Immunodeficiency Syndrome | 3 |
| Immunologic Deficiency Syndromes | 2 |
| Chlamydia Infections | 1 |
| Gonorrhea | 1 |
| Hepatitis | 1 |
| Hepatitis, Viral, Human | 1 |
| Infections | 1 |
| Lentivirus Infections | 1 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.